Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
Nature
|
July 9, 2025
Loss of FCoV-23 spike domain 0 enhances fusogenicity and entry kinetics
M Alejandra Tortorici, Annette Choi, Cecily A Gibson, et al.
Plos One
|
February 8, 2019
Correction: Modeling suggests that microliter volumes of contaminated blood caused an outbreak of hepatitis C during computerized tomography
Eyal Shteyer, Louis Shekhtman, Tal Zinger, et al.
Plos One
|
January 16, 2019
Modeling suggests that microliter volumes of contaminated blood caused an outbreak of hepatitis C during computerized tomography
Eyal Shteyer, Louis Shekhtman, Tal Zinger, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
November 9, 2023
Dual anti-viral treatment for persistent COVID-19 in immunocompromised hemato-oncological patients is associated with a favorable prognosis and minor side effects
Suzy E Meijer, Ora Halutz, Amos Adler, et al.
Nature Medicine
|
June 15, 2021
Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals
Talia Kustin, Noam Harel, Uriah Finkel, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
Nature
|
July 9, 2025
Loss of FCoV-23 spike domain 0 enhances fusogenicity and entry kinetics
M Alejandra Tortorici, Annette Choi, Cecily A Gibson, et al.
Plos One
|
February 8, 2019
Correction: Modeling suggests that microliter volumes of contaminated blood caused an outbreak of hepatitis C during computerized tomography
Eyal Shteyer, Louis Shekhtman, Tal Zinger, et al.
Plos One
|
January 16, 2019
Modeling suggests that microliter volumes of contaminated blood caused an outbreak of hepatitis C during computerized tomography
Eyal Shteyer, Louis Shekhtman, Tal Zinger, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
November 9, 2023
Dual anti-viral treatment for persistent COVID-19 in immunocompromised hemato-oncological patients is associated with a favorable prognosis and minor side effects
Suzy E Meijer, Ora Halutz, Amos Adler, et al.
Nature Medicine
|
June 15, 2021
Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals
Talia Kustin, Noam Harel, Uriah Finkel, et al.
Page
of 2